|
AL-BEHADILL ET AL.: "A two-nuclease pathway involving RNase Hl is required for primer removal at human mitochondrial OriL", NUCLEIC ACIDS RES., vol. 46, no. 18, 2018, pages 9471 - 9483
|
|
ASTROM ET AL.: "Oligonucleotide based artificial nuclease (OBAN) systems. Bulge size dependence and positioning of catalytic group in cleavage of RNA-bulges", ORG. BIMOL. CHEM., vol. 1, 2003, pages 1461 - 1465, XP055753618, DOI: 10.1039/b212216b
|
|
ASTROMSTROMBERG: "Synthesis of new OBAN's and further studies on positioning of the catalytic group", ORG. BIOMOL. CHEM., vol. 2, 2004, pages 1901 - 1907
|
|
BELOGLAZOVA ET AL.: "Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy", NUCLEIC ACIDS RES., vol. 32, 2004, pages 3887 - 3897
|
|
BENNETT ET AL.: "Pharmacology of Antisense Drugs", ANNU. REV. PHARMACOL. TOXICOL. 6, vol. 57, 2017, pages 81 - 105, XP055851477, DOI: 10.1146/annurev-pharmtox-010716-104846
|
|
BENNETTSWAYZE: "RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform", ANNU. REV. PHARMACOL. TOXICOL., vol. 50, 2010, pages 259 - 293, XP055055378, DOI: 10.1146/annurev.pharmtox.010909.105654
|
|
CASINERI: "Antibody-drug conjugates and small molecule-drug conjugates: opportunities and challenges for the development of selective anticancer cytotoxic agents", J. MED. CHEM., vol. 58, 2015, pages 8751 - 8761, XP055473740, DOI: 10.1021/acs.jmedchem.5b00457
|
|
CHANG ET AL.: "CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo", SCI. REP., vol. 6, 2016, pages 22312, XP055549675, DOI: 10.1038/srep22312
|
|
CHARI: "Targeted cancer therapy: conferring specificity to cytotoxic drugs", ACC. CHEM. RES., vol. 41, 2008, pages 98 - 107, XP008146241, DOI: 10.1021/ar700108g
|
|
CHOI ET AL.: "Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430", SCIENCE, vol. 318, 2007, pages 271 - 274, XP055199883, DOI: 10.1126/science.1147535
|
|
COSTALES ET AL.: "Small Molecule Targeted Recruitment of a Nuclease to RNA", PNAS USA, vol. 140, 2018, pages 6741 - 6744
|
|
CROOKE, MOLECULAR MECHANISMS OF ANTISENSE OLIGONUCLEOTIDES NULEIC ACID THERAPEUTICS, vol. 27, no. 2, 2017, pages 70 - 77
|
|
DANNEBERG ET AL.: "Sequence-specific RNA cleavage by PNA conjugates of the metal-free artificial ribonuclease tris(2-aminobenzimidazole", BELLSTEIN J. ORG. CHEM, vol. 11, 2015, pages 403 - 498
|
|
DERKSEN ET AL.: "RNase P-mediated sequence-specific cleavage of RNA by engineered external guide sequences", BIOMOLECULES, vol. 5, 2015, pages 3029 - 3050
|
|
DI GIORGIO ET AL.: "Small-molecule approaches toward the targeting of oncogenic miRNAs: Roadmap for the discovery of RNA modulators", FUTURE MED. CHEM., vol. 8, 2016, pages 803 - 816
|
|
DOGANDZHIYSKI ET AL.: "Studies on Tris(2-aminobenzimidazole)-PNA Based Artificial Nucleases: A Comparison of Two Analytical Techniques", BIOCONJUG. CHEM., vol. 26, 2015, pages 2514 - 2519, XP055618083, DOI: 10.1021/acs.bioconjchem.5b00534
|
|
EBERT ET AL.: "MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells", NATURE METHODS, vol. 4, 2007, pages 721 - 726, XP055248938, DOI: 10.1038/nmeth1079
|
|
FRIXA ET AL.: "Oncogenic MicroRNAs: Key Players in Malignant Transformation", CANCERS (BASEL, vol. 7, 2015, pages 2466 - 2485
|
|
GAMBARI ET AL.: "Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology", INT. J. ONCOL., vol. 49, 2016, pages 5 - 32, XP055460168, DOI: 10.3892/ijo.2016.3503
|
|
GARZON ET AL.: "Targeting microRNAs in cancer: rationale, strategies and challenges", NAT. REV. DRUG DISCOV., vol. 9, 2010, pages 775 - 789, XP055228752, DOI: 10.1038/nrd3179
|
|
GUMIREDDY ET AL.: "Small-molecule inhibitors of microrna miR-21 function", ANGEW CHEM. INT. ED. ENGL., vol. 47, 2008, pages 7482 - 7484, XP055198586, DOI: 10.1002/anie.200801555
|
|
HANER ET AL.: "Development of artificial ribonucleases", PURE APPL. CHEM., vol. 70, 1998, pages 111 - 116
|
|
HOLOCHMOAZED: "RNA-mediated epigenetic regulation of gene expression", NAT REV GENET., vol. 16, 2015, pages 71 - 84
|
|
HUO ET AL.: "Lentiviral CRISPR/Cas9 vector mediated miR-21 gene editing inhibits the epithelial to mesenchymal transition in ovarian cancer cells", J. CANCER, vol. 8, 2017, pages 57 - 64, XP055550172, DOI: 10.7150/jca.16723
|
|
HUSKEN ET AL.: "Creating RNA Bulges: Cleavage of RNA in RNA/DNA Duplexes by Metal Ion Catalysis", BIOCHEM., vol. 35, 1996, pages 16591 - 16600
|
|
IZSVAKIVICS: "Sleeping Beauty transposition: biology and applications for molecular therapy", MOL. THER., vol. 9, 2004, pages 147 - 156, XP002622340, DOI: 10.1016/j.ymthe.2003.11.009
|
|
JUNG ET AL.: "Simultaneous inhibition of multiple oncogenic miRNAs by a multi-potent microRNA sponge", ONCOTARGET, vol. 6, 2015, pages 20370 - 20387, XP055248863, DOI: 10.18632/oncotarget.4827
|
|
KALE ET AL.: "RNA therapeutics: beyond RNA interference and antisense oligonucleotides", NAT. REV. DRUG DISCOVERY, vol. 11, 2012, pages 125 - 140
|
|
KANAYA ET AL.: "A hybrid ribonuclease H. A novel RNA cleaving enzyme with sequence-specific recognition", J. BIOL. CHEM., vol. 267, 1992, pages 8492 - 8498
|
|
KAUKINEN ET AL.: "The cleavage of phosphodiester bonds within small RNA bulges in the presence and absence of metal ion catalysts", J. CHEM. SOC. PERKIN TRANS., vol. 2, 2001, pages 1024 - 1031
|
|
KUZNETSOVA ET AL.: "Cleavage of RNA bulge loops by artificial RNases", RUSS. CHEM. BULL. (INT. EDIT., vol. 55, no. 7, 2006, pages 1284 - 1294, XP019454006, DOI: 10.1007/s11172-006-0412-y
|
|
KUZNETSOVA ET AL.: "Enhanced RNA cleavage within bulge-loops by an artificial ribonuclease", NUCLEIC ACIDS RES., vol. 33, no. 4, 2005, pages 1201 - 1212
|
|
LENNOX ET AL.: "Non-nucleotide Modification of Anti-miRNA Oligonucleotides", METHODS MOL. BIOL., vol. 1517, 2017, pages 51 - 69
|
|
LENNOXBEHLKE: "Chemical modification and design of anti-miRNA oligonucleotides", GENE THERAPY, vol. 18, 2011, pages 1111 - 1120, XP055156922, DOI: 10.1038/gt.2011.100
|
|
LIANG ET AL.: "RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus", MOLECULAR THERAPY, vol. 25, no. 9, 2017, pages 2075 - 2092, XP055575667, DOI: 10.1016/j.ymthe.2017.06.002
|
|
LORENZ ET AL.: "High-throughput platform assay technology for the discovery of pre-microrna-selective small molecule probes", BIOCONJUG. CHEM., vol. 26, 2015, pages 19 - 23, XP055391811, DOI: 10.1021/bc500544v
|
|
MAGDA ET AL.: "Metal complex conjugates of antisense DNA which display ribozyme-like activity", JACS USA, vol. 119, 1997, pages 6947 - 6948
|
|
MAKAROVA ET AL.: "Evolution and classification of the CRISPR-Cas systems", NATURE REVIEWS. MICROBIOLOGY, vol. 9, 2011, pages 467 - 477, XP009155547, DOI: 10.1038/nrmicro2577
|
|
MARKOU ET AL.: "Clinical evaluation of microRNA expression profiling in non-small cell lung cancer", LUNG CANCER, vol. 81, 2013, pages 388 - 396
|
|
MCCLAIN ET AL.: "Model substrates for an RNA enzyme", SCIENCE, vol. 238, 1987, pages 527 - 530, XP055613876, DOI: 10.1126/science.2443980
|
|
MENG ET AL.: "Small RNA zippers lock miRNA molecules and block miRNA function in mammalian cells", NATURE COMMUN., vol. 8, 2017, pages 3964
|
|
MIRONOVA ET AL.: "Covalently attached oligodeoxyribonucleotides induce RNase activity of a short peptide and modulate its base specificity", NUCLEIC ACIDS RES., vol. 32, 2004, pages 1928 - 1936
|
|
MIRONOVA ET AL.: "G-specific RNA-cleaving conjugates of short peptides and oligodeoxyribonucleotides", J. BIOMOL. STRUCT. DYN., vol. 23, 2006, pages 591 - 602
|
|
MIRONOVA ET AL.: "Ribonuclease activity of the peptides with alternating arginine and leucine residues conjugated to tetrathymidilate", NUCLEOS. NUCLEOT., vol. 23, 2004, pages 885 - 890
|
|
MIRONOVA ET AL.: "RNase T1 mimicking artificial ribonuclease", NUCLEIC ACIDS RES., vol. 35, 2007, pages 2356 - 2367
|
|
MIRONOVA ET AL.: "Sequence-specific cleavage of the target RNA with oligonucleotide-peptide conjugates", RUSS. CHEM. BULL., vol. 51, 2002, pages 1177 - 1186
|
|
MIROSHNICHENKO ET AL.: "2'OMe Modification of Anti-miRNA-21 Oligonucleotide-Peptide Conjugate Improves Its Hybridization Properties and Catalytic Activity", RUSSIAN J. BIOORG. CHEM., vol. 45, no. 6, 2019, pages 803 - 812, XP036990407, DOI: 10.1134/S1068162019060281
|
|
MIROSHNICHENKO ET AL.: "Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates: improved biochemical and biological properties", PNAS, 2019, pages 201813376
|
|
MOELLING ET AL.: "RNase H As Gene Modifier, Driver of Evolution and Antiviral Defense", FRONTIERS IN MICROBIOL., vol. 8, 2017, pages 1745
|
|
MURTOLA ET AL.: "PNAzymes that are artificial RNA restriction enzymes", J. AM. CHEM. SOC., vol. 132, 2010, pages 8984 - 90
|
|
NIITTYMAKI ET AL.: "Preparation of azacrown-functionalized 2'-0-methyl oligoribonucleotides, potential artificial RNases", BIOCONJUGATE CHEM., vol. 15, 2004, pages 174
|
|
NIITTYMAKILONNBERG: "Artificial ribonucleases", ORG. BIOMOL. CHEM., vol. 4, 2006, pages 15 - 25
|
|
O'BRYANA ET AL.: "The roles of oncogenic miRNAs and their therapeutic importance in breast cancer", EUR. J. CANCER, vol. 72, 2017, pages 1 - 11, XP029889864, DOI: 10.1016/j.ejca.2016.11.004
|
|
PATUTINA ET AL.: "Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model", FRONT. PHARMACOL., vol. 10, 2019, pages 879
|
|
PATUTINA ET AL.: "Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance", MOLECULES, vol. 25, 2020, pages 2459
|
|
PATUTINA ET AL.: "miRNases: Novel peptide-oligonucleotide bioconjugates that silence miR-21 in lymphosarcoma cells", BIOMATERIALS, vol. 122, 2017, pages 163 - 178
|
|
PATUTINA ET AL.: "Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H", NATURE SCIENTIFIC REP., vol. 8, 2018, pages 14990
|
|
PYSHNYI ET AL.: "Oligonucleotide-peptide conjugates for RNA cleavage", NUCLEOS. NUCLEOT., vol. 16, 1997, pages 1571 - 1574
|
|
ROMEROBARRIOS ET AL.: "Splicing regulation by long noncoding RNAs", NUCLEIC ACIDS RES., vol. 46, 2018, pages 2169 - 2184
|
|
SCANNELL ET AL.: "Diagnosing the Decline in Pharmaceutical R&D Efficiency", NATURE REV. DRUG DISCOV., vol. 11, 2012, pages 191 - 200
|
|
SCHEFFER ET AL.: "Metal-Free Catalysts for the Hydrolysis of RNA Derived from Guanidines, 2-Aminopyridines, and 2-Aminobenzimidazoles", JACS USA, vol. 127, 2005, pages 2211 - 2217, XP055267677, DOI: 10.1021/ja0443934
|
|
STAROSELETZ ET AL.: "Dual' peptidyl-oligonucleotide conjugates: role of conformational flexibility in catalytic cleavage of RNA", BIOMATERIALS, vol. 112, 2017, pages 44 - 61, XP029812693, DOI: 10.1016/j.biomaterials.2016.09.033
|
|
STAROSELETZ ET AL.: "Strict conformational demands of RNA cleavage in bulge-loops created by peptidyl-oligonucleotide conjugates", NUCLEIC ACIDS RESEARCH, vol. 48, no. 19, 2020, pages 10662
|
|
TAHIRI ET AL.: "Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors", CARCINOGENESIS, vol. 35, 2014, pages 76 - 85
|
|
TRAWICK ET AL.: "Enhancing sequence-specific cleavage of RNA within a duplex region: incorporation of 1,3-propanediol linkers into oligonucleotide conjugates of serinol-terpyridine", BIOCONJUGATE CHEM., vol. 12, 2001, pages 900
|
|
WANG: "The principles of MiRNA-masking antisense oligonucleotides technology", METHODS MOL. BIOL., vol. 676, 2011, pages 43 - 49
|
|
WILLIAMS ET AL.: "Peptidyl-oligonucleotide conjugates demonstrate efficient cleavage of RNA in a sequence-specific manner", BIOCONJUG. CHEM., vol. 26, 2015, pages 1129 - 1143
|
|
XIAO ET AL.: "Novel approaches for gene-specific interference via manipulating actions of microRNAs: examination on the pacemaker channel genes HCN2 and HCN4", J. CELL PHYSIOL., vol. 212, 2007, pages 285 - 292, XP002481763, DOI: 10.1002/jcp.21062
|
|
ZHANG ET AL.: "Non-coding RNAs and retroviruses", RETROVIROLOGY, vol. 15, 2018, pages 20
|
|
ZHOU ET AL.: "New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network", FRONT. MOL. BIOSCI., vol. 4, 2017, pages 46
|
|
ZUCKERMANNSCHULTZ: "Site-selective cleavage of structured RNA by a staphylococcal nuclease-DNA hybrid", PNAS USA, vol. 86, 1989, pages 1766 - 70
|